Study to Evaluate Long-Term Safety, Tolerability, and Satisfaction With Prucalopride in Chronic Constipation
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Objectives: To evaluate the clinical long-term safety and the tolerability, patient
satisfaction, pharmacokinetics and use of pattern of prucalopride given in doses up to 4 mg
per day to patients with chronic constipation (CC).